Catalytic mechanism of human alpha-galactosidase.

The Journal of Biological Chemistry
Abigail I GuceScott C Garman

Abstract

The enzyme alpha-galactosidase (alpha-GAL, also known as alpha-GAL A; E.C. 3.2.1.22) is responsible for the breakdown of alpha-galactosides in the lysosome. Defects in human alpha-GAL lead to the development of Fabry disease, a lysosomal storage disorder characterized by the buildup of alpha-galactosylated substrates in the tissues. alpha-GAL is an active target of clinical research: there are currently two treatment options for Fabry disease, recombinant enzyme replacement therapy (approved in the United States in 2003) and pharmacological chaperone therapy (currently in clinical trials). Previously, we have reported the structure of human alpha-GAL, which revealed the overall structure of the enzyme and established the locations of hundreds of mutations that lead to the development of Fabry disease. Here, we describe the catalytic mechanism of the enzyme derived from x-ray crystal structures of each of the four stages of the double displacement reaction mechanism. Use of a difluoro-alpha-galactopyranoside allowed trapping of a covalent intermediate. The ensemble of structures reveals distortion of the ligand into a (1)S(3) skew (or twist) boat conformation in the middle of the reaction cycle. The high resolution structures of...Continue Reading

References

Feb 1, 1992·Biochemical Society Transactions·J S ReidA H Clark
Mar 1, 1991·Acta Crystallographica. Section A, Foundations of Crystallography·T A JonesM Kjeldgaard
Jan 1, 1996·Annual Review of Biochemistry·W I Weis, K Drickamer
Feb 7, 1998·Structure·G J Kleywegt, R J Read
Mar 29, 2000·Accounts of Chemical Research·D L Zechel, S G Withers
Jun 21, 2001·JAMA : the Journal of the American Medical Association·R SchiffmannR O Brady
Jul 7, 2001·The New England Journal of Medicine·A FrustaciR J Desnick
Jul 7, 2001·The New England Journal of Medicine·C M EngUNKNOWN International Collaborative Fabry Disease Study Group
Dec 3, 2002·Nature Reviews. Genetics·Robert J Desnick, Edward H Schuchman
Mar 27, 2003·The Journal of Biological Chemistry·Zui FujimotoHiroshi Mizuno
Jun 14, 2003·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Roscoe O Brady
Feb 20, 2004·Journal of the American Chemical Society·Marie-Pierre HeckCharles Mioskowski
Mar 9, 2004·Journal of Molecular Biology·Scott C Garman, David N Garboczi
Oct 27, 2004·The Journal of Biological Chemistry·Andrew L LoveringNatalie C J Strynadka
Jul 18, 2006·Planta·Bozena ChrostKarin Krupinska
Mar 28, 2007·Journal of the American Chemical Society·Jacqueline WickiStephen G Withers
Mar 30, 2007·Acta Paediatrica. Supplement·Scott C Garman
Apr 3, 2007·Nature Biotechnology·Qiyong P LiuHenrik Clausen
Apr 11, 2007·The Journal of Biological Chemistry·Thomas R M BarendsBauke W Dijkstra
Nov 1, 2007·British Journal of Haematology·Martin L Olsson, Henrik Clausen
Apr 15, 2008·Nature Chemical Biology·Louise E TailfordGideon J Davies
Jun 19, 2008·Current Opinion in Chemical Biology·David J Vocadlo, Gideon J Davies
Oct 8, 2008·Nucleic Acids Research·Brandi L CantarelBernard Henrissat
Jan 1, 1997·Methods in Enzymology·Zbyszek Otwinowski, Wladek Minor

❮ Previous
Next ❯

Citations

Oct 10, 2012·Proceedings of the National Academy of Sciences of the United States of America·Nathaniel E ClarkScott C Garman
May 7, 2010·The Journal of Biological Chemistry·Ivan B TomasicScott C Garman
May 27, 2011·Assay and Drug Development Technologies·Kenneth J ValenzanoElfrida R Benjamin
Nov 26, 2010·Orphanet Journal of Rare Diseases·Dominique P Germain
Dec 9, 2010·Orphanet Journal of Rare Diseases·Giuseppina AndreottiMaria Vittoria Cubellis
Dec 4, 2013·Proceedings of the National Academy of Sciences of the United States of America·Chris H HillJanet E Deane
Jul 30, 2014·Future Medicinal Chemistry·Giancarlo ParentiGeneroso Andria
Mar 1, 2013·Applied Biochemistry and Biotechnology·Neelesh SinghArvind M Kayastha
Aug 2, 2015·Heart Failure Reviews·Aashish SharmaClaudio Ronco
Apr 17, 2015·Molecular Therapy : the Journal of the American Society of Gene Therapy·Giancarlo ParentiKenneth J Valenzano
May 4, 2016·Cellular and Molecular Life Sciences : CMLS·Masayuki OkuyamaAtsuo Kimura
Feb 27, 2015·PloS One·Mariam MeghdariDavid H Calhoun
Dec 20, 2012·The Journal of Physical Chemistry. B·Xiao-Liang PanJing-Yao Liu
Aug 12, 2014·Journal of the American Chemical Society·Lianne I WillemsHerman S Overkleeft
Sep 20, 2011·Accounts of Chemical Research·Gideon J DaviesCarme Rovira
Dec 28, 2017·Chemistry : a European Journal·Jean-François NierengartenPhilippe Compain
Jun 17, 2010·Biotechnology and Bioengineering·Thu V Vuong, David B Wilson
Jun 30, 2011·Critical Reviews in Biotechnology·Sven CuyversChristophe M Courtin
Nov 6, 2014·Acta Crystallographica. Section D, Biological Crystallography·Shifra LanskyGil Shoham
Sep 6, 2015·The Journal of Biological Chemistry·Natalie C BamfordDonald C Sheppard
Sep 4, 2015·The Journal of Biological Chemistry·Yuka OkazawaTakashi Tonozuka
Jun 6, 2015·Protein Science : a Publication of the Protein Society·Huawei QiuTim Edmunds
Jun 28, 2020·Critical Reviews in Food Science and Nutrition·Maria Micaela UretaAndrea Gomez-Zavaglia
Apr 23, 2020·Frontiers in Plant Science·Kassiani KytidouJohannes M F G Aerts
Jun 29, 2012·Chembiochem : a European Journal of Chemical Biology·Dietlind AdlercreutzMonica M Palcic
Aug 28, 2017·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Thi Minh Nguyet TrinhJean-François Nierengarten
Nov 21, 2019·International Journal of Biological Macromolecules·Sonu BhatiaJagtar Singh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Glycosides

Cardiac glycosides are a diverse family of naturally derived compounds that bind to and inhibit na+/k+-atpase. Discover the latest research on cardiac glycosides heres.

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.